FLORIDA, USA. July 23rd, 2025 — Mind Lab Pro® v4.0, the flagship nootropic from Performance Lab® Group, has again proven its effectiveness in enhancing brain function. A new peer-reviewed study, conducted by the University of Leeds, confirms the supplement’s ability to improve brain network efficiency and functional connectivity – key
CAMBRIDGE, MA, USA. July 15th, 2025 — SciSure, formerly SciShield and eLabNext, is proud to announce the formal sponsorship of The Engine, a nonprofit founded by MIT to incubate and accelerate early-stage Tough Tech companies from idea to impact. This sponsorship marks the next step in a partnership rooted in
Nottingham, UK. July 7th 2025 – Upperton Pharma Solutions, a leading Nottingham-based pharmaceutical contract development and manufacturing organisation (CDMO), is delighted to announce its recognition as the winner of the Business Expansion award in the Integrated Manufacturing category at the 2025 Pharmaceutical Technology Excellence Awards. Powered by the global insights
FLORIDA, USA. June 25th, 2025 – Performance Lab® Group has developed the first nootropic that has been scientifically proven to work. A peer-reviewed study published in the Biomedical Journal of Scientific & Technical Research shows that the Mind Lab Pro® v4.0 supplement noticeably improves simple reaction time, choice reaction time,
BOSTON MA. June 13th, 2025 – SciSure, the Scientific Management Platform (SMP) designed to unify scientific research, safety, operations, and compliance, today announced a strategic partnership with US Lab Partners, a leader in lab and facility operations and EHS (Environmental Health & Safety) consulting. Together, the organizations are launching a
Boston, USA. April 4th 2025 – GA International, a global leader in laboratory identification solutions, under its LabTAG brand, announced today that its DYMO® LabelWriter™ 5-Series Printing Kits are now compatible with eLabNext’s Digital Lab Platform (DLP) — an intuitive and flexible system for collecting, managing, and analyzing laboratory information.
NOTTINGHAM, UK. 3rd April, 2025 – 4D Biomaterials Ltd, the materials manufacturing subsidiary of 4D Medicine Ltd, a UK university spin-out company developing next-generation bioresorbable medical devices, today announced it has achieved ISO 13485:2016 certification from The British Standards Institution (BSI). This globally recognised quality standard for medical device manufacturing
NOTTINGHAM, UK. March 11th, 2025 – 4D Medicine Ltd, an emerging innovator in the biomaterials and medical device sector, is proud to announce the launch of its newly redesigned corporate website, www.4dmedicine.co.uk. The site is designed to offer a comprehensive resource for investors, strategic partners, and healthcare professionals, highlighting the
BOSTON, MA. March 5th, 2025 – Today, protocols.io, a platform that enables academic and industry researchers to record and share up-to-date methods for research, announced that, under eLabNext leadership, its platform is now available for integration with eLabNext’s Digital Lab Platform (DLP), an intuitive and flexible system for collecting, managing,